Vivione Biosciences | RAPID-B Technology
Vivione Biosciences is powered by RAPID-B technology, an integrated system of hardware, software and wetware that tests bacteria in key environments.
Our mission is to revolutionize the clinical and medical fields, food and industrial safety, water safety and biodefense by utilizing one compact, universal platform for all diagnostic testing that can be used for bacteria, viruses and toxins.
Taking the place of outdated culture-based, immunology-based and molecular-based methods that take countless hours and many times, days, RAPID-B provides more accurate results for each of these fields in minutes to a few hours.
Our technology has combined flow cytometry with our own proprietary reagents to achieve a single cell detection capability in minutes. Unlike culture-based methods, the RAPID-B system does not require isolation of bacteria. It works with the background interference from complex matrices like food.
- Life Sciences
Fayetteville startup BiologicsMD has been awarded a U.S. patent for the development of fusion proteins that help in the treatment of bone and hair loss.
Ozark Integrated Circuits of Fayetteville has received two grants from NASA to develop heat-resistant circuits that can operate on the surface of Venus and AEDC board approval to further develop its patent-pending UV detector.
The Venture Center launched its Pitch 'N Pint series of startup pitch contests at the Flying Saucer in Little Rock's River Market District.
Before founding EquityNet in 2005, Judd Hollas was division manager for Beta-Rubicon Inc. of Fayetteville, a consulting firm specializing in technology assessment and business due diligence services. He has 20 years of experience as an independent technology analyst and investment manager in the private and public domains.